Clinical Trial Update: MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

View source ↗

Summary

A clinical trial is recruiting to evaluate MAsS Scan as a predictor of morbidity and mortality in patients with liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Snippet

Sponsor: University of Chicago | Conditions: Liver Diseases | Status: RECRUITING